Cherrington Julie M — SEC Form 4 filings

SEC reporting owner CIK 1781315. 5 Form 4 filings on record with FilingPulse; latest filed 2025-07-24.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-23 to 2025-07-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Elevation Oncology, Inc. (ELEV)Director46
Mirati Therapeutics, Inc. (MRTX)Director13

Form 4 filings — Cherrington Julie M

FiledFormIssuerReported transactionsSource
2025-07-244Elevation Oncology, Inc. (ELEV)Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0EDGAR
2025-06-094Elevation Oncology, Inc. (ELEV)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-06-174Elevation Oncology, Inc. (ELEV)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-03-044Elevation Oncology, Inc. (ELEV)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 4,444 · Disposition to issuer (D): 6,808 · Disposition to issuer (D): 7,520 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1781315 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →